Skip to content

Impact of Linked Color Imaging on Sessile Serrated Lesion Miss Rate

Impact of Linked Color Imaging on Sessile Serrated Lesion Miss Rate: a Multicenter Tandem Rondomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07745842
Enrollment
2072
Registered
2026-08-04
Start date
2026-08-01
Completion date
2029-02-01
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Sessile Serrated Lesion

Brief summary

This prospective, multicenter randomized controlled trial aimed to investigate whether linked color imaging (LCI) could reduce the miss rate of sessile serrated lesions (SSLs) during tandem colonoscopy compared with conventional white-light imaging (WLI).

Interventions

PROCEDUREWLI Then LCI Withdrawal

Patients in the WLI then LCI withdrawal group first underwent careful endoscopic inspection with white-light imaging (WLI). The endoscopic setting was then switched to linked color imaging (LCI) for the second withdrawal. All polyps detected during both inspection passes were resected, and the number of lesions missed on the first withdrawal was subsequently calculated.

PROCEDURELCI Then WLI Withdrawal

Patients in the LCI then WLI withdrawal group first underwent careful endoscopic inspection with linked color imaging (LCI). The endoscopic setting was then switched to white-light imaging (WLI) for the second withdrawal. All polyps detected during both inspection passes were resected, and the number of lesions missed on the first withdrawal was subsequently calculated.

Sponsors

Nanfang Hospital, Southern Medical University
Lead SponsorOTHER
Shunde First People's Hospital of Foshan
CollaboratorUNKNOWN
ZhuHai Hospital
CollaboratorOTHER
Jiangmen Central Hospital
CollaboratorOTHER
Yangjiang People's Hospital
CollaboratorOTHER
Zhongshan Guzhen People's Hospital
CollaboratorUNKNOWN
Sihui Wanlong Hospital
CollaboratorUNKNOWN
The Third People's Hospital of Huizhou
CollaboratorOTHER
Longgang District People's Hospital of Shenzhen
CollaboratorOTHER
Suixi People's Hospital of Zhanjiang
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Subjects aged ≥45 years, regardless of gender; 2. Subjects undergoing screening colonoscopy; 3. Subjects with no prior colonoscopy; 4. Voluntarily provide written informed consent.

Exclusion criteria

1. Subjects unable to cooperate with or tolerate colonoscopy; 2. Subjects with inflammatory bowel disease; 3. Known or highly suspected colorectal obstruction; 4. History of colorectal surgery; 5. Chronic recurrent constipation; 6. Failure to discontinue anticoagulants or antiplatelet agents for at least 1 week before the procedure; 7. Poor bowel preparation with an inadequate Aronchick scale score during colonoscopy; 8. Failed cecal intubation; 9. High-risk conditions including severe cardiovascular and cerebrovascular diseases, uncorrected severe anemia or active infection; 10. Pregnant or breastfeeding women; 11. Subjects deemed ineligible for participation in this trial at the investigator's discretion.

Design outcomes

Primary

MeasureTime frameDescription
sessile serrated lesions miss rate(SSLMR)One dayThe number of SSL detected in the second-pass examination/total number of SSL detected in both two pass.

Secondary

MeasureTime frameDescription
adenoma miss rate (AMR)One dayThe number of adenomas detected in the second-pass examination/total number of adenomas detected in the two pass.
advanced adenomas miss rate (AAMR)One daythe number of advanced adenomas detected in the second-pass examination/total number of advanced adenomas detected in the two pass.
polyps miss rate (PMR)One daythe number of polyps detected in the second-pass examination/total number of polyps detected in the two pass.
sessile serrated lesions detection rate (SSLDR)One daythe number of patients with at least one sessile serrated lesion detected by linked color imaging or white light imaging, divided by the total number of patients.
adenomas detection rate (ADR)One daythe number of patients with at least one adenoma detected by linked color imaging or white light imaging, divided by the total number of patients.
advanced adenomas detection rate (AADR)One daythe number of patients with at least one advanced adenoma detected by linked color imaging or white light imaging, divided by the total number of patients.
polyps detection rate (PDR)One daythe number of patients with at least one polyp detected by linked color imaging or white light imaging, divided by the total number of patients.

Contacts

CONTACTZelong Han, MD
hanzelong2025@163.com+86 20-6278-7385
CONTACTBitao Lin, MD
linbitao1996@163.com+86 137-2532-1385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026